NanoString Technologies, Inc. (NSTG): Price and Financial Metrics


NanoString Technologies, Inc. (NSTG): $43.82

-0.63 (-1.42%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

NSTG POWR Grades


  • NSTG scores best on the Growth dimension, with a Growth rank ahead of 63.01% of US stocks.
  • The strongest trend for NSTG is in Quality, which has been heading up over the past 51 weeks.
  • NSTG ranks lowest in Sentiment; there it ranks in the 18th percentile.

NSTG Stock Summary

  • With a price/sales ratio of 15.15, NanoString Technologies Inc has a higher such ratio than 87.79% of stocks in our set.
  • With a year-over-year growth in debt of 26.31%, NanoString Technologies Inc's debt growth rate surpasses 80.47% of about US stocks.
  • Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for NSTG comes in at -11.8% -- higher than that of just 19.23% of stocks in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to NanoString Technologies Inc are AFIB, MYOV, PSTG, LPSN, and QTWO.
  • Visit NSTG's SEC page to see the company's official filings. To visit the company's web site, go to www.nanostring.com.

NSTG Valuation Summary

  • NSTG's price/sales ratio is 19.8; this is 421.05% higher than that of the median Healthcare stock.
  • Over the past 100 months, NSTG's EV/EBIT ratio has gone down 25.8.
  • NSTG's EV/EBIT ratio has moved down 25.8 over the prior 100 months.

Below are key valuation metrics over time for NSTG.

Stock Date P/S P/B P/E EV/EBIT
NSTG 2021-08-31 19.8 12.1 -26.7 -31.6
NSTG 2021-08-30 19.8 12.0 -26.7 -31.5
NSTG 2021-08-27 19.6 11.9 -26.4 -31.3
NSTG 2021-08-26 19.0 11.6 -25.6 -30.4
NSTG 2021-08-25 19.3 11.7 -26.0 -30.8
NSTG 2021-08-24 19.6 11.9 -26.4 -31.2

NSTG Growth Metrics

  • Its 5 year net cashflow from operations growth rate is now at -105.31%.
  • Its 2 year net cashflow from operations growth rate is now at -64.59%.
  • The year over year price growth rate now stands at 88.58%.
Over the past 67 months, NSTG's revenue has gone up $70,920,000.

The table below shows NSTG's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-06-30 133.587 -75.69 -99.053
2021-03-31 122.328 -82.735 -99.166
2020-12-31 117.316 -81.662 -110.078
2020-09-30 117.985 -90.318 -63.087
2020-06-30 116.744 -90.404 -64.518
2020-03-31 124.485 -89.027 -57.422

NSTG's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • NSTG has a Quality Grade of D, ranking ahead of 22.47% of graded US stocks.
  • NSTG's asset turnover comes in at 0.28 -- ranking 160th of 680 Pharmaceutical Products stocks.
  • FOLD, CLVS, and RDUS are the stocks whose asset turnover ratios are most correlated with NSTG.

The table below shows NSTG's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.280 0.537 -0.226
2021-03-31 0.281 0.534 -0.257
2020-12-31 0.295 0.553 -0.281
2020-09-30 0.362 0.572 -0.147
2020-06-30 0.392 0.594 -0.163
2020-03-31 0.462 0.628 -0.156

NSTG Price Target

For more insight on analysts targets of NSTG, see our NSTG price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $45.67 Average Broker Recommendation 1.4 (Strong Buy)

NSTG Stock Price Chart Interactive Chart >

Price chart for NSTG

NSTG Price/Volume Stats

Current price $43.82 52-week high $86.42
Prev. close $44.45 52-week low $34.31
Day low $43.81 Volume 846,200
Day high $45.32 Avg. volume 547,327
50-day MA $52.97 Dividend yield N/A
200-day MA $62.59 Market Cap 1.99B

NanoString Technologies, Inc. (NSTG) Company Bio


NanoString Technologies provides life science tools for translational research and molecular diagnostic products. The company was founded in 2003 and is based in Seattle, Washington.


NSTG Latest News Stream


Event/Time News Detail
Loading, please wait...

NSTG Latest Social Stream


Loading social stream, please wait...

View Full NSTG Social Stream

Latest NSTG News From Around the Web

Below are the latest news stories about NanoString Technologies Inc that investors may wish to consider to help them evaluate NSTG as an investment opportunity.

NanoString Launches nCounter Antibody Drug Conjugate Panel to Accelerate the Development of Oncology Treatments

SEATTLE, October 12, 2021--NanoString announces the launch of the nCounter® ADC Development Panel.

Yahoo | October 12, 2021

NanoString Technologies Inc (NSTG): Price Now Near $43.71; Daily Chart Shows Downtrend on 50 Day Basis

The moving averages on the daily timeframe suggest a bearishness in price, as the 20, 50, 100 and 200 are all in a bearish alignment -- meaning the shorter duration moving averages are below the longer duration averages, implying a stable downward trend. The post NanoString Technologies Inc (NSTG): Price Now Near $43.71; Daily Chart Shows Downtrend on 50 Day Basis appeared first on ETF Daily News .

ETF Daily News | October 8, 2021

10 Small-Cap Stocks to Buy According to ‘Australia’s Warren Buffett’ Kerr Neilson

In this article, we discuss the 10 small-cap stocks to buy according to Australian billionaire Kerr Neilson. If you want to skip our detailed analysis of Neilson’s history, investment philosophy, and hedge fund performance, go directly to the 5 Small-Cap Stocks to Buy According to Australian Billionaire Kerr Neilson. Billionaire Kerr Neilson co-founded Platinum Asset […]

Yahoo | October 6, 2021

NanoString to Release Third Quarter 2021 Operating Results and Host Conference Call on Tuesday, November 9, 2021

SEATTLE, October 06, 2021--NanoString to host third quarter 2021 operating results webcast on Tuesday, November 9th, 2021.

Yahoo | October 6, 2021

Tech Moves: Bioengineer joins AI2 incubator; Icosavax adds execs, expands board; and more

The Allen Institute for AI (AI2) added bioengineer Jenny Cronin as an associate working with entrepreneurs in AI2s startup incubator. Im excited about the potential human health benefits and discoveries well see by leveraging AI in the biotech and healthcare spaces, said Cronin in an email to GeekWire. Cronin was most recently a senior science communications advisor at s2s Public Relations and previously a product manager at NanoString Technologies. She has her doctorate in bioengineering from the University of Washington where she researched brain-computer interfaces. Biotech startups Ozette and Modulus, and health-tech startup MajorBoost have all incubated at AI2. Read More

GeekWire | September 16, 2021

Read More 'NSTG' Stories Here

NSTG Price Returns

1-mo -24.04%
3-mo -27.06%
6-mo -39.42%
1-year 8.98%
3-year 189.05%
5-year 119.76%
YTD -34.48%
2020 140.40%
2019 87.59%
2018 98.53%
2017 -66.50%
2016 51.60%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 1.0283 seconds.